Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$10.38 +0.54 (+5.49%)
At close: Aug 21, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018)

Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Change in Receivables of -$6.2 million for Q2 2018, little changed quarter-over-quarter from -$6.2 million in Q1 2018.

Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018) Analysis & Trends

Corbus Pharmaceuticals Holdings' Change in Receivables history runs 2 years deep, the most recent figure standing at -$6.2 million for Q2 2018.

  • In Q2 2018, Change in Receivables changed N/A year-over-year to -$6.2 million; the TTM figure through Sep 2019 stood at -$6.2 million (up 51.92% YoY), while the FY2019 annual figure was -$5.0 million, up 60.0% from the prior year.
  • Change in Receivables for Q2 2018 stood at -$6.2 million, roughly flat from -$6.2 million in the prior quarter.
  • The five-year high for Change in Receivables was $500000.0 in Q3 2017, with the low at -$6.2 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -53.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 117.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 31.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 94.29 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 37.16 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Corbus Pharmaceuticals Holdings 127.63 Mn -35.64 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 -6.25 Mn
Jun 30, 2018 -6.25 Mn
Mar 31, 2018 -6.25 Mn
Mar 31, 2018 -6.25 Mn
Dec 31, 2017 -500,000.00
Dec 31, 2017 -500,000.00
Sep 30, 2017 500,000.00
Sep 30, 2017 500,000.00
Mar 31, 2017 -1.00 Mn
Mar 31, 2017 -1.00 Mn